Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.22.4
Segment Information (Tables)
 3 Months Ended
Dec. 25, 2022
Segment Reporting [Abstract]  
Revenues, EBT, and Assets for reportable segments
The table below presents revenues and EBT for reportable segments (in millions):
Three Months Ended
December 25,
2022		 December 26,
2021
Revenues
QCT $ 7,892  $ 8,847 
QTL 1,524  1,818 
QSI 7  8 
Reconciling items 40  32 
Total $ 9,463  $ 10,705 
EBT
QCT $ 2,183  $ 3,114 
QTL 1,117  1,406 
QSI (8) 122 
Reconciling items (921) (777)
Total $ 2,371  $ 3,865 
Reconciling items for reportable segments - revenues
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 25,
2022		 December 26,
2021
Revenues
Nonreportable segments $ 40  $ 32 
$ 40  $ 32 
EBT
Unallocated cost of revenues $ (65) $ (53)
Unallocated research and development expenses (522) (453)
Unallocated selling, general and administrative expenses (167) (152)
Unallocated other expenses (Note 2) (80) — 
Unallocated interest expense (170) (139)
Unallocated investment and other income, net 87  23 
Nonreportable segments (4) (3)
$ (921) $ (777)
Reconciling items for reportable segments - EBT
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
Three Months Ended
December 25,
2022		 December 26,
2021
Revenues
Nonreportable segments $ 40  $ 32 
$ 40  $ 32 
EBT
Unallocated cost of revenues $ (65) $ (53)
Unallocated research and development expenses (522) (453)
Unallocated selling, general and administrative expenses (167) (152)
Unallocated other expenses (Note 2) (80) — 
Unallocated interest expense (170) (139)
Unallocated investment and other income, net 87  23 
Nonreportable segments (4) (3)
$ (921) $ (777)